NUS

LIPMAN ANDREW D

Known title: DirectorCIK: 0001184208

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Nu Skin: Turnaround Narrative Gains Attention. A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.

this person other insiders at NUS

Transaction History

NUS▼ Sell$27K
NUS▼ Sell$25K
NUS▼ Sell$25K
NUS▼ Sell$25K
NUS▼ Sell$37K
NUS▼ Sell$39K
NUS▼ Sell$34K
NUS▼ Sell$272K
NUS▼ Sell$38K
NUS▼ Sell$46K
NUS▼ Sell$47K
NUS▼ Sell$58K
NUS▼ Sell$64K
NUS▲ Buy$0
NUS▼ Sell$69K
NUS▼ Sell$82K
NUS▼ Sell$79K
NUS▼ Sell$41K
NUS▼ Sell$42K
NUS▼ Sell$41K
NUS▼ Sell$38K
NUS▼ Sell$36K
NUS▼ Sell$37K
NUS▼ Sell$45K
NUS▼ Sell$43K
NUS▼ Sell$44K
NUS▲ Buy$0
NUS▼ Sell$45K
NUS▼ Sell$48K
NUS▼ Sell$47K
NUS▼ Sell$53K
NUS▼ Sell$51K

We use analytics to understand how market-wall is used. No personal data is sold.